Is the FTSE 100 now the worst place to look for stocks?

Should you cross FTSE 100 (INDEXFTSE:UKX) companies off your shopping list?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

You might think that the FTSE 100 is now barren ground for picking winning shares. After all, the index has made a tremendous recovery since the 2008/9 bear market and posted strong gains since June’s Brexit vote.

However, while the unprecedented stimulus measures post-2008/9 have sent share prices soaring, many heavyweight blue chips have been struggling to grow their revenues and earnings. Let me show you what I mean.

Reasons to feel blue about blue chips

Last year, almost half of the companies in the FTSE 100 posted a fall in their revenues. Meanwhile, many companies have posted rising profits purely due to cost-cutting rather than business growth, something that isn’t sustainable in the long run. In other cases we’ve seen earnings growth produced by companies leaving out lots of ‘nasties’, so that ‘adjusted’ earnings look good, while real earnings may be negative. Finally, FTSE 100 companies have been buying back billions of their own shares, which has the effect of flattering their earnings.

So, share prices and dividends have raced higher, even though, in many cases, companies haven’t really been growing. According to the FTSE Actuaries, the top index is now trading at a sky-high earnings multiple (P/E) of over 36. Furthermore, dividend cover is just 0.75, which means that a quarter of shareholders’ payouts are being funded from the companies’ balance sheets — in most cases by increased borrowings.

Given the high valuation of the FTSE 100, and the number of companies struggling to grow their top lines, increasing their profits cosmetically and borrowing cash to fund their dividends, is the index now the worst place to look for winning stocks. Should we be turning our backs on the heavyweight blue chips and looking instead to younger, nimbler companies that are set to grow their revenues and profits rapidly from relatively low bases?

Smaller company appeal

I’m certainly coming across many smaller companies that are forecast to grow at rates that show a clean pair of heels to the average FTSE 100 company. In the last 10 days alone I’ve written about a tasty retailer that’s just posted a 229% rise in profit, a holiday specialist bucking the tough travel market, and a niche e-tailer and a leisure firm that are forecast to grow earnings by 43% and 55% respectively.

Now, while companies such as these have tremendous growth prospects and are certainly worth considering, there’s no such thing as a free lunch. Many of them trade on really high earnings multiples, and being young, rapidly expanding businesses there is a higher risk in executing on their growth strategies. Smaller companies rarely progress without the odd hiccup or setback and, of course, some end up not prospering at all.

So, while I think there is a place for small cap growth stocks in the portfolios of most investors, I wouldn’t turn my back on the FTSE 100 for some core holdings.

Back to blue chips

Not only is the sheer size and relative stability of blue chips appealing, but also a number of these heavyweights are now set to put their struggles with revenue and earnings growth behind them. Shell, GlaxoSmithKline, Vodafone and Tesco are just four popular names that are on track for a resurgence in growth this year and in the years ahead.

So, the FTSE 100 appears to be far from the worst place to look for stocks that can deliver winning returns for investors.

G A Chester has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended Royal Dutch Shell B. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

What on earth’s going to happen to the BP share price in 2026?

Harvey Jones looks at how the BP share price is shaping up for the year ahead, and finds investors have…

Read more »

Bearded man writing on notepad in front of computer
Investing Articles

Have a £20,000 lump sum? Here’s how to target a £8,667 yearly passive income

How to turn £20,000 into a £8,667 passive income? Our Foolish author explains one counterintuitive strategy to build such an…

Read more »

British coins and bank notes scattered on a surface
Dividend Shares

2 dividend stocks that yield double the current UK interest rate

Following the latest UK interest rate cut, Jon Smith points out a couple of options that offer generous income relative…

Read more »

Investing Articles

A 9% yield and now this! Check out the stunning Taylor Wimpey share price forecast for 2026

Harvey Jones has kept the faith in Taylor Wimpey shares despite a difficult run, bolstered by their incredible yield. Next…

Read more »

Investing Articles

How much do you need in an ISA to aim for a life-changing passive income of £30,000 a year?

Harvey Jones says ISA savers can transform their futures in 2026 by investing in FTSE 100 dividend stocks with huge…

Read more »

Investing Articles

My top 10 ISA and SIPP stocks in 2026

Find out why a FTSE 100 investment trust is now this writer's top holding across his Stocks and Shares ISA…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

£10,000 invested in Rolls-Royce shares 5 Christmases ago is now worth…

James Beard reflects on the post-pandemic Rolls-Royce share price rally and whether the group could become the UK’s most valuable…

Read more »

Investing Articles

Will Nvidia shares continue their epic run into 2026 and beyond?

Nvidia shares have an aura of invincibility as an AI boom continues to benefit the chipmaker. Can anything stop the…

Read more »